Human Genome Epidemiology Literature Finder
|
Records 1 - 17 (of 17 Records) |
| Query Trace: Colorectal Neoplasms and UGT1A[original query] |
|---|
| Polymorphisms of uridine-diphosphoglucuronosyltransferase 1A7 gene in Taiwan Chinese. World journal of gastroenterology : WJG 2005 Feb 11 (6): 797-802. Huang May-Jen, Yang Sien-Sing, Lin Min-Shung, Huang Ching-Sh |
| [Polymorphisms of UGT1A gene and irinotecan toxicity in Chinese colorectal cancer patients]. Zhonghua zhong liu za zhi [Chinese journal of oncology] 2007 Dec 29 (12): 913-6. Wang Yan, Xu Jian-Ming, Shen Lin, Xu Nong, Wang Jin-Wan, Jiao Shun-Chang, Zhang Jing-Sheng, Song San-Tai, Li Jian, Bao Han-Ying, Yang Lin, Li Fa |
| Gilbert's Syndrome and irinotecan toxicity: combination with UDP-glucuronosyltransferase 1A7 variants increases risk. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2008 Mar 17 (3): 695-701. Lankisch Tim O, Schulz Christoph, Zwingers Thomas, Erichsen Thomas J, Manns Michael P, Heinemann Volker, Strassburg Christian |
| Predictive role of the UGT1A1, UGT1A7, and UGT1A9 genetic variants and their haplotypes on the outcome of metastatic colorectal cancer patients treated with fluorouracil, leucovorin, and irinotecan. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009 May 27 (15): 2457-65. Cecchin Erika, Innocenti Federico, D'Andrea Mario, Corona Giuseppe, De Mattia Elena, Biason Paola, Buonadonna Angela, Toffoli Giusep |
| UGT1A and TYMS genetic variants predict toxicity and response of colorectal cancer patients treated with first-line irinotecan and fluorouracil combination therapy. British journal of cancer 2010 Aug 103 (4): 581-9. Martinez-Balibrea E, Abad A, Martínez-Cardús A, Ginés A, Valladares M, Navarro M, Aranda E, Marcuello E, Benavides M, Massutí B, Carrato A, Layos L, Manzano J L, Moreno |
| Meat-related mutagen exposure, xenobiotic metabolizing gene polymorphisms and the risk of advanced colorectal adenoma and cancer. Carcinogenesis 2012 Jul 33 (7): 1332-9. Gilsing Anne M J, Berndt Sonja I, Ruder Elizabeth H, Graubard Barry I, Ferrucci Leah M, Burdett Laura, Weissfeld Joel L, Cross Amanda J, Sinha Rash |
| UGT1A1*6, 1A7*3, and 1A9*22 genotypes predict severe neutropenia in FOLFIRI-treated metastatic colorectal cancer in two prospective studies in Japan. Cancer science 2013 Dec 104 (12): 1662-9. Hazama Shoichi, Mishima Hideyuki, Tsunedomi Ryouichi, Okuyama Yusuke, Kato Takeshi, Takahashi Ken-ichi, Nozawa Hiroshi, Ando Hideaki, Kobayashi Michiya, Takemoto Hiroyoshi, Nagata Naoki, Kanekiyo Shinsuke, Inoue Yuka, Hamamoto Yoshihiko, Fujita Yusuke, Hinoda Yuji, Okayama Naoko, Oba Koji, Sakamoto Jun-ichi, Oka Masaa |
| Polymorphic expression of UDP-glucuronosyltransferase UGTlA gene in human colorectal cancer. PloS one 2013 8 (2): e57045. Wang Min, Sun De-Feng, Wang Shuai, Qing Ying, Chen Shuo, Wu Dong, Lin Ying-Min, Luo Ji-Zhuang, Li Yan-Qi |
| Refining the UGT1A haplotype associated with irinotecan-induced hematological toxicity in metastatic colorectal cancer patients treated with 5-fluorouracil/irinotecan-based regimens. The Journal of pharmacology and experimental therapeutics 2013 Apr 345 (1): 95-101. Lévesque Eric, Bélanger Anne-Sophie, Harvey Mario, Couture Félix, Jonker Derek, Innocenti Federico, Cecchin Erica, Toffoli Giuseppe, Guillemette Chant |
| A novel system for predicting the toxicity of irinotecan based on statistical pattern recognition with UGT1A genotypes. International journal of oncology 2014 Oct 45 (4): 1381-90. Tsunedomi Ryouichi, Hazama Shoichi, Fujita Yusuke, Okayama Naoko, Kanekiyo Shinsuke, Inoue Yuka, Yoshino Shigefumi, Yamasaki Takahiro, Suehiro Yutaka, Oba Koji, Mishima Hideyuki, Sakamoto Junichi, Hamamoto Yoshihiko, Oka Masaa |
| The effect of UGT1A and UGT2B polymorphisms on colorectal cancer risk: haplotype associations and gene–environment interactions. Genes, chromosomes & cancer 2014 Jun 53 (6): 454-66. Angstadt Andrea Y, Hartman Terryl J, Lesko Samuel M, Muscat Joshua E, Zhu Junjia, Gallagher Carla J, Lazarus Phil |
| Examination of multiple UGT1A and DPYD polymorphisms has limited ability to predict the toxicity and efficacy of metastatic colorectal cancer treated with irinotecan-based chemotherapy: a retrospective analysis. BMC cancer 2017 Jun 17 (1): 437. Liu Dan, Li Jian, Gao Jing, Li Yanyan, Yang Rui, Shen L |
| Clinical and pharmacogenetic determinants of 5-fluorouracyl/leucovorin/irinotecan toxicity: Results of the PETACC-3 trial. European journal of cancer (Oxford, England : 1990) 2018 Jun 99 66-77. Tejpar Sabine, Yan Pu, Piessevaux Hubert, Dietrich Daniel, Brauchli Peter, Klingbiel Dirk, Fiocca Roberto, Delorenzi Mauro, Bosman Fred, Roth Arnaud |
| UGT1A polymorphisms associated with worse outcome in colorectal cancer patients treated with irinotecan-based chemotherapy. Cancer chemotherapy and pharmacology 2018 May . Yu Qianqian, Zhang Tao, Xie Conghua, Qiu Hong, Liu Bo, Huang Liu, Peng Ping, Feng Jueping, Chen Jigui, Zang Aihua, Yuan Xiangl |
| Effect of UGT, SLCO, ABCB and ABCC polymorphisms on irinotecan toxicity. Medicina clinica 2018 Feb . García Gil Sara, Ramos Díaz Ruth, Nazco Casariego Gloria Julia, Llanos Muñoz Marta, Viña Romero Maria Micaela, Martín Calero Braulio, Pérez Pérez Jose Antonio, Gutiérrez Nicolás Fernan |
| Pharmacogenetic clinical randomised phase II trial to evaluate the efficacy and safety of FOLFIRI with high-dose irinotecan (HD-FOLFIRI) in metastatic colorectal cancer patients according to their UGT1A 1 genotype. British journal of cancer 2019 Jan 120 (2): 190-195. Páez David, Tobeña María, Fernández-Plana Julen, Sebio Ana, Virgili Anna C, Cirera Lluís, Barnadas Agustí, Riera Pau, Sullivan Ivana, Salazar Julia |
| Association between a single nucleotide polymorphism in the R3HCC1 gene and irinotecan toxicity. Cancer medicine 2022 10 . Kanesada Kou, Tsunedomi Ryouichi, Hazama Shoichi, Ogihara Hiroyuki, Hamamoto Yoshihiko, Shindo Yoshitaro, Matsui Hiroto, Tokumitsu Yukio, Yoshida Shin, Iida Michihisa, Suzuki Nobuaki, Takeda Shigeru, Ioka Tatsuya, Nagano Hiroa |
- Page last reviewed:Feb 1, 2024
- Content source: